Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80.
Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure.
HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design.
Small steps forward for HIV vaccine development.
A Summary of the Fourth Annual Virology Education HIV Microbiome Workshop.
Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection.
Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease.
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control.
Dasatinib protects humanized mice from acute HIV-1 infection.
Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial.